Clinical supervision: analysis of postoperative pain evaluation in the ambulatory surgery setting / Supervisão clínica: análise da avaliação da dor pós-operatória em cirurgia de ambulatório

Clinical supervision, as a formal process of monitoring professional practice, aims to improve decision-making to contribute to safety and quality of care through reflection processes and analysis of clinical practice. This study aimed to compare the postoperative pain evaluation and clinical recording procedures performed by nursing staff and clinical supervisors in ambulatory surgery patients.The study was integrated into the research project "SAFECARE". It was developed a descriptive cross-sectional quantitative study in an ambulatory surgery unit of a University Hospital in Oporto, Portugal. The study population was the nursing staff with an intentional non-probabilistic sampling method. A questionnaire was constructed and evaluation of postoperative pain, patient clinical and demographic variables was included. This instrument was applied in 116 patients matched by 12 surgical specialties. Results were compared between nursing staff, clinical supervisors and electronic nursing records. Patients had an average age of 48.6 years, being mostly female. Regarding pain evaluation, the scale most used by nurses (62.1%) and clinical supervisors (67.2%) was the "Numerical Scale". Postoperative pain evaluation scores ranged from 0 to 7, with score 0 (no pain) presenting more frequently by nurses, electronic nursing records and clinical supervisors. 34.5% of results were not documented in electronic nursing records. These findings support the importance of an intervention of clinical supervision in the indicator "pain" for the outpatient surgery setting. Local protocols of clinical supervision practice would contribute to improve postoperative pain evaluation, as well as standardization and optimization of nursing records, thus ensuring quality care

No disponible

Implementação de um modelo de supervisão clínica em enfermagem - modelo safecare / Implementation of a nursing clinical supervision model - SAFECARE model

The actual context, marked by the high cost of health care associated with technological advances, the increase in the workload of health professionals and the aging of the population with multiple chronic diseases. There are concerns raised by health organizations regarding the quality of care, with emphasis on actions aimed to the continuous quality improvement. The effects of clinical supervision on quality of care defined as a target area by the World Health Organization are a key aspect in improving quality. The literature shows that there is no model of nursing clinical supervision capable to respond to the actual context needs. The objective of this exploratory, descriptive and longitudinal study was to implement a contextualized nursing clinical supervision model, SafeCare model, in order to identify the contributions of its implementation in the indicators sensitive to nursing clinical supervision. The study was conducted in the surgery department of a health care institution and the nurses of the surgery department composed the sample. With this article we intend to disseminate the results of the implementation of the SafeCare model and to prove that the implementation of a contextualized Nursing clinical supervision model based on nurses' needs, SafeCare Model, has contributed to obtaining higher quality and safer care for clients

No disponible

Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates.

In this paper, we report the synthesis and pharmacological evaluation of pyrazine N-acylhydrazone (NAH) derivatives (2a-s) designed as novel analgesic and anti-inflammatory drug candidates. This series was planned by molecular simplification of prototype 1 (LASSBio-1018), previously described as a non-selective cyclooxygenase inhibitor. Derivatives 2a-s were evaluated in several animal models of pain and inflammation, standing-out compound 2o (2-N'-[(E)-(3,4,5-trimethoxyphenyl) methylidene]-2-pyrazinecarbohydrazide; LASSBio-1181), that was also active in a murine model of chronic inflammation (i.e., adjuvant-induced arthritis test in rats) and can be considered a new analgesic and anti-inflammatory lead for drug development.